IFM Investors Pty Ltd Buys 1,996 Shares of Intuitive Surgical, Inc. $ISRG

IFM Investors Pty Ltd raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 76,149 shares of the medical equipment provider’s stock after buying an additional 1,996 shares during the quarter. IFM Investors Pty Ltd’s holdings in Intuitive Surgical were worth $35,104,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Severin Investments LLC purchased a new position in Intuitive Surgical during the first quarter valued at approximately $424,000. Key Financial Inc lifted its stake in Intuitive Surgical by 178.3% in the 1st quarter. Key Financial Inc now owns 167 shares of the medical equipment provider’s stock worth $77,000 after purchasing an additional 107 shares in the last quarter. First Pacific Financial lifted its stake in Intuitive Surgical by 105.6% in the 1st quarter. First Pacific Financial now owns 111 shares of the medical equipment provider’s stock worth $51,000 after purchasing an additional 57 shares in the last quarter. MQS Management LLC bought a new position in Intuitive Surgical in the 1st quarter valued at $513,000. Finally, Eagle Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 15.7% in the 1st quarter. Eagle Wealth Advisors LLC now owns 1,237 shares of the medical equipment provider’s stock valued at $570,000 after purchasing an additional 168 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In related news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the sale, the executive vice president owned 5,720 shares in the company, valued at $2,426,080.80. The trade was a 6.54% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total value of $236,730.00. Following the completion of the sale, the director directly owned 239 shares of the company’s stock, valued at approximately $113,156.94. This represents a 67.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 7,169 shares of company stock worth $3,059,135. 0.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Jefferies Financial Group decreased their price target on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a report on Wednesday, April 22nd. Mizuho set a $525.00 price objective on Intuitive Surgical and gave the company a “neutral” rating in a research note on Monday, April 13th. Leerink Partners reduced their target price on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Finally, The Goldman Sachs Group set a $558.00 price target on Intuitive Surgical in a report on Wednesday, May 27th. Nineteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $573.42.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $397.68 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $396.68 and a 52-week high of $603.88. The firm has a fifty day moving average of $430.20 and a 200 day moving average of $481.84. The firm has a market capitalization of $140.84 billion, a PE ratio of 48.20, a price-to-earnings-growth ratio of 3.30 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter last year, the business posted $1.81 earnings per share. The company’s revenue for the quarter was up 23.0% on a year-over-year basis. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.